DiaMedica Therapeutics Inc (DMAC)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 527k | 0 | 0 | 0 | 0 |
Operating Income | -3.13M | -3.97M | -5.52M | -4.21M | -5.16M | -5.85M | -5.74M | -5.64M |
Pre Tax Income | -3.05M | -3.74M | -5.27M | -4.47M | -4.46M | -5.14M | -5.14M | -5.11M |
Net Income | -3.06M | -3.75M | -5.27M | -4.48M | -4.47M | -5.16M | -5.15M | -5.12M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -3M | -3.74M | -5.27M | -4.21M | -3.94M | -5.14M | -5.14M | -5.11M |
EBITDA | -3.11M | -3.97M | -5.44M | -4.3M | -5.14M | -5.77M | -5.73M | -5.55M |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 222k | 324k | 1.71M | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.26M | -4.08M | -5.55M | -11.59M | -12.7M | -13.65M | -14M | -21.27M |
Pre Tax Income | -2.2M | -4.14M | -5.65M | -10.62M | -12.27M | -13.56M | -13.65M | -19.34M |
Net Income | -2.22M | -4.18M | -5.73M | -10.65M | -12.29M | -13.59M | -13.68M | -19.38M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.02 | -0.033 | -0.48 | -0.887 | -0.656 | -0.514 | -0.517 | -0.511 |
EBIT | -2.26M | -4.08M | -5.65M | -10.62M | -12.27M | -13.56M | -13.65M | -19.34M |
EBITDA | -2.26M | -4.07M | -5.55M | -11.57M | -12.68M | -13.62M | -13.98M | -21.17M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.